期刊文献+

病毒性肝炎后肝硬化住院患者感染状况调查及危险因素分析 被引量:7

Investigetion of the infections and assessment of the risk factors in hospitalized patients with posthepatitic cirrhosis
原文传递
导出
摘要 目的 调查病毒性肝炎后肝硬化住院患者的感染率和感染源,评估感染的危险因素.方法 采用横断面研究,连续收集382例病毒性肝炎后肝硬化住院患者,查阅患者相关临床资料,采用单因素分析、逻辑回归分析等方法分析患者感染相关因素和独立危险因素,微生物培养和鉴定分析感染源.结果 通过调查统计肝硬化住院患者感染率20.2%,77名患者感染,最常见感染是自发性细菌性腹膜炎(27例),感染显著增加患者的死亡(22.1%vs.4.3%,P≤0.001)和延长住院时间(10 d vs.22 d,P≤0.001).逻辑回归分析显示胃肠道出血和低白蛋白血症是肝硬化住院患者感染独立危险因素;共分离出66株菌,革兰阴性菌38株,革兰阳性菌26株,真菌2株.结论 感染增加病毒性肝炎后肝硬化住院患者死亡;胃肠道出血和低白蛋白血症是导致肝硬化住院患者感染独立危险因素. Objective To investigate the infection rate in hospitalized patients with posthepatitic cirrhosis and to assess the risk factors of infections.Methods The prospective study was performed to assess the risk of infection in 382 hospitalized patients with posthepatitic cirrhosis.The clinical and laboratory data were collected.Univariate analysis and Logistic regression were used to analyse the risk fachors and independent risk factors of infections.Results 20.2% patients developed an infection during their hospitalization.Spontaneous bacterial peritonitis (SBP) (35.1%) were the most common infections.Death in patients with infections was higher than that of non-infection patients (22.1% vs.4.3%,P ≤ 0.001).Logistic regression identified gastrointestinal bleeding (A =4.2,95% CI =1.8-10.7) and a low serum albumin (OR =1.4,95% CI =1.05-1.23) as the only two variables independently associated with the development of an infection.There were 66 isolates isolated including 38 gram-negtive bacteria,26 gram-positive bacteria,and 2 fungi.Conclusion Infections could increase the death rate in patients with posthepatitic cirrhosis.Patients with posthepatitic cirrhosis who were admitted for gastrointestinal bleeding and low serum albumin level have a higher risk of developing a infection during their hospitalization than other cirrhotic patients.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2014年第1期41-43,共3页 Chinese Journal of Experimental and Clinical Virology
关键词 肝硬化 感染 Liver cirrhosis Infection
  • 相关文献

参考文献13

  • 1Wong F,Salerno F. Beta-blockers in cirrhosis:friend and foe[J].{H}HEPATOLOGY,2010.811-813.
  • 2Toledo C,Flores C,Sáenz M. Bacterial infections in hepatic cirrhosis[J].{H}Revista Medica de Chile,1994.788-794.
  • 3Borzio M,Salerno F,Piantoni L. Bacterial infection in patients with advanced cirrhosis:a multicentre prospective study[J].{H}Digestive and Liver Disease,2001.41-48.
  • 4Mathurin S,Chapelet A,Spanevello V. Infections in hospitalized patients with cirrhosis[J].{H}Medicina(B Aires),2009.229-238.
  • 5de Mattos AA,Coral GP,Menti E. Bacterial infection in cirrhotic patient[J].Arg Gastroenterol,2003.l1-15.
  • 6Tandon P,Delisle A,Topal JE. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center[J].{H}Clinical Gastroenterology and Hepatology,2012.1291-1298.
  • 7Shizuma T,Fukuyama N. Investigation into bacteremia and spontaneous bacterial peritonitis in patients with liver cirrhosis in Japan[J].TurkJGastroenterol,2012.122-126.
  • 8Tandon P,Garcia-Tsao G. Bacterial infections,sepsis,and multiorgan failure in cirrhosis[J].{H}Seminars in Liver Disease,2008.26-42.
  • 9Bonnel AR,Bunchorntavakul C,Reddy KR. Immune dysfunction and infections in patients with cirrhosis[J].{H}Clinical Gastroenterology and Hepatology,2011.727-738.
  • 10Wong F,Bernardi M,Balk R. Sepsis in cirrhosis:report on the 7th meeting of the International Ascites Club[J].{H}GUT,2005.718-725.

同被引文献73

  • 1Michela Emma Burlone,Stefano Fangazio,Alessandro Croce,Elisa Ceriani,Rachele Rapetti,Cristina Rigamonti,Carlo Smirne,Stelvio Tonello,Paolo Ravanini,Rosalba Minisini,Mario Pirisi.Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment[J].Hepatoma Research,2020,6(2):1-10. 被引量:1
  • 2中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,390:579-616.
  • 3Yang YY,Hsieh SL,Lee PC,et al. Long-termcannabinoid type 2 receptor agonist therapy decreasesbacterial translocation in rats with cirrhosis and ascites[J].J Hepatol, 2014, 61 ( 15 ) : 1004-1013.
  • 4Miura K, Tanaka A, Yamamoto T, et al. Proton pumpinhibitor use is associated with spontaneous bacterialperitonitis in patients with liver cirrhosis [J].Intem Med,2014,53 ( 10) : 1037-1042.
  • 5Lesi ft ska M , Hartleb M , Gutkowski K , etal.Procalcitonin and macrophage inflammatory protein-1beta ( MIP-1 P ) in serum and peritoneal fluid ofpatients with decompensated cirrhosis and spontaneousbacterial peritonitis [J].Adv Med Sci, 2014,59 ( 1 ):52-56.
  • 6P 6 rez-Cameo C, Vargas V,Castells L,et al. Etiologyand mortality of spontaneous bacterial peritonitis in livertransplant recipients : a cohort study[J].Liver Transpl,2014, 20 (7) : 856-863.
  • 7Lutz P, Parcina M, Bekeredjian-Ding I, et al.Impactof rifaximin on the frequency and characteristics ofspontaneous bacterial peritonitis in patients with livercirrhosis and ascites[J].PLoS One, 2014, 9(4):e93909.
  • 8Wehmeyer MH, Krohm S, Kastein F, et al.Predictionof spontaneous bacterial peritonitis in cirrhotic ascites bya simple scoring system[J].Scand J Gastroenterol, 2014,49 ( 5 ) : 595-603.
  • 9Gines P, Cardenas A. The management of ascites and hyponatremia in cirrhosis[J]. Semin Liver Dis,200S,2S:43-5S .
  • 10Faber W, Stockmann M, Schirmer C, et al. Significant impact of patient age on outcome after liver resection for HCC in cirrhosis[J]. Eur J Surg Oncol,2014,40:20S-213.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部